Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Industry Summary Page

Industry: pharmaceuticals
Penalty Total since 2000: $116,245,163,450
Number of Records: 1,270
Note: The totals include only those entries matched to a parent company. The industry designation is the primary one for the parent's operations overall. The totals are adjusted to account for the fact that each parent's entries may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. They are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the individual records list below.
Top 10 Current Parent CompaniesTotal Penalty $Number of Records
Johnson & Johnson$24,497,162,77088
Pfizer$10,948,368,52398
Merck$10,710,400,03189
Teva Pharmaceutical Industries$10,242,576,79696
GlaxoSmithKline$9,572,803,40650
Purdue Pharma$9,278,372,78711
AbbVie$7,560,456,40484
Takeda Pharmaceutical$3,987,516,44732
Endo International$3,311,990,66730
Eli Lilly$2,831,299,67626

Individual Penalty Records:

Click on the company or penalty amount for more information on each case. Click on the parent name to reach the summary page for that parent company.

Download results as CSV or XML or Save your search (Click here for information on download subscriptions)
CompanyCurrent ParentPrimary Offense TypeYearAgencyPenalty Amount sort icon
Bristol-Myers Squibb CompanyBristol-Myers Squibbprice-fixing or anti-competitive practices2003private lawsuit-federal$220,000,000
AstraZeneca Pharmaceuticals LPAstraZenecaoff-label or unapproved promotion of medical products2010MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $218,092,993
Taro Pharmaceuticals USA, Inc.Sun PharmaceuticalsFalse Claims Act and related2021DOJ_CIVIL$213,200,000
United Therapeutics CorporationUnited TherapeuticsFalse Claims Act and related2017DOJ_CIVIL$210,000,000
Elan Corporation PLCPerrigooff-label or unapproved promotion of medical products2010FDA$203,000,000
Merck Sharp & Dohme Corp.Merckoff-label or unapproved promotion of medical products2012MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $201,975,000
Allergan Finance LLCAbbVieoff-label or unapproved promotion of medical products2021NY-AG$200,000,000
AstraZenecaAstraZenecadrug or medical equipment safety violation2010private lawsuit-federal$198,000,000
Sandoz Inc.Sandoz Groupprice-fixing or anti-competitive practices2020DOJ_ANTITRUST$195,000,000
Endo Health Solutions Inc.Endo Internationaloff-label or unapproved promotion of medical products2014FDA$192,700,000
Aventis Pharmaceuticals Inc.SanofiFalse Claims Act and related2007DOJ_CIVIL$190,000,000
Warner-LambertPfizeroff-label or unapproved promotion of medical products2004MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $190,000,000
Pfizer Inc.Pfizerprice-fixing or anti-competitive practices2014private lawsuit-federal$190,000,000
Bristol-Myers SquibbBristol-Myers SquibbFalse Claims Act and related2008MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $187,000,000
Sandoz Inc.Sandoz GroupFalse Claims Act and related2021DOJ_CIVIL$185,000,000
Janssen Pharmaceuticals, Inc.Johnson & Johnsonoff-label or unapproved promotion of medical products2012MULTI-AG$181,000,000
Novartis CorporationNovartisemployment discrimination2010private lawsuit-federal$175,000,000
GlaxoSmithKlineGlaxoSmithKlineprice-fixing or anti-competitive practices2004private lawsuit-federal$175,000,000
Endo Health SolutionEndo Internationaloff-label or unapproved promotion of medical products2014MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $173,000,000
Teva Pharmaceuticals Inc.Teva Pharmaceutical IndustriesFalse Claims Act and related2010MULTI-AG$169,000,000
Forest Pharmaceuticals Inc.AbbVieoff-label or unapproved promotion of medical products2011FDA$164,000,000
SB Pharmco Puerto Rico Inc.GlaxoSmithKlinedrug or medical equipment safety violation2010MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $163,560,000
Purdue Frederick Company Inc.Purdue PharmaFalse Claims Act and related2007MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $160,000,000
Johnson & JohnsonJohnson & Johnsonoff-label or unapproved promotion of medical products2012TX-AG$158,000,000
Par Pharmaceuticals, Inc.Endo InternationalFalse Claims Act and related2011MULTI-AG$154,000,000
GlaxoSmithKlineGlaxoSmithKlineFalse Claims Act and related2005DOJ_CIVIL$150,000,000
Bristol-Myers Squibb CompanyBristol-Myers Squibbaccounting fraud or deficiencies2004SEC$150,000,000
Janssen Pharmaceuticals, Inc.Johnson & Johnsonproduct safety violation2022private lawsuit-federal$150,000,000
GlaxoSmithKline PLCGlaxoSmithKlineprice-fixing or anti-competitive practices2013private lawsuit-federal$150,000,000
Lupin Pharmaceuticals Inc.Lupin Limitedprice-fixing or anti-competitive practices2022private lawsuit-federal$150,000,000
Sandoz Inc.Sandoz Groupprice-fixing or anti-competitive practices2011private lawsuit-federal$150,000,000
TAP Pharmaceutical ProductsTakeda Pharmaceuticalprice-fixing or anti-competitive practices2005private lawsuit-federal$150,000,000
Hikma PharmaceuticalsHikma Pharmaceuticalsoff-label or unapproved promotion of medical products2024MULTI-AG$150,000,000
Johnson & JohnsonJohnson & Johnsonoff-label or unapproved promotion of medical products2024WA-AG$149,500,000
Forest Pharmaceuticals Inc.AbbVieFalse Claims Act and related2010USAO$149,000,000
Valeant Pharmaceuticals International, Inc.Bausch Healthinvestor protection violation2017MULTI-AG$145,000,000
Impax Laboratories, Inc.Amneal Pharmaceuticalsprice-fixing or anti-competitive practices2022private lawsuit-federal$145,000,000
Hoffman-LaRocheRocheprice-fixing or anti-competitive practices2000MULTI-AG$142,494,000
Allergan Ltd. et al.AbbVieoff-label or unapproved promotion of medical products2022FL-AG$134,200,000
Hoffmann-La RocheRocheprice-fixing or anti-competitive practices2000private lawsuit-federal$130,000,000
Novartis AGNovartisprice-fixing or anti-competitive practices2023private lawsuit-federal$126,850,000
Abbott Laboratories Inc.AbbVieFalse Claims Act and related2010DOJ_CIVIL$126,500,000
Warner Chilcott PLCAbbVieoff-label or unapproved promotion of medical products2015FDA$125,000,000
CephalonTeva Pharmaceutical Industriesconsumer protection violation2016MULTI-AG$125,000,000
King PharmaceuticalsPfizerFalse Claims Act and related2005DOJ_CIVIL$124,000,000
King PharmaceuticalsPfizerFalse Claims Act and related2006MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $124,000,000
Johnson & JohnsonJohnson & Johnsondrug or medical equipment safety violation2019MULTI-AG$120,000,000
Allergan PLCAbbVieprice-fixing or anti-competitive practices2020private lawsuit-federal$120,000,000
Actavis Mid-Atlantic LLCTeva Pharmaceutical Industriesprice-fixing or anti-competitive practices2011private lawsuit-federal$118,614,000
Mylan Pharmaceuticals and UDL LaboratoriesViatrisFalse Claims Act and related2009DOJ_CIVIL$118,000,000
Mylan Pharmaceuticals, Inc.ViatrisFalse Claims Act and related2009MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $118,000,000
Johnson & JohnsonJohnson & Johnsondrug or medical equipment safety violation2019MULTI-AG$116,860,000
Cephalon Inc.Teva Pharmaceutical Industriesoff-label or unapproved promotion of medical products2008MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $116,000,000
Avanir PharmaceuticalsOtsuka PharmaceuticalFalse Claims Act and related2019DOJ_CIVIL$115,874,895
Novartis AGNovartisForeign Corrupt Practices Act2020SEC$112,800,000
AstraZenecaAstraZenecaFalse Claims Act and related2018TX-AG$110,000,000
Sanofi-Aventis U.S. Inc.SanofiFalse Claims Act and related2012DOJ_CIVIL$109,000,000
Mylan Laboratories et al.Viatrisprice-fixing or anti-competitive practices2000MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $108,000,000
GlaxoSmithKline, LLCGlaxoSmithKlinekickbacks and bribery2014MULTI-AG$105,000,000
Novartis Pharmaceuticals Corp.Novartiskickbacks and bribery2020MULTI-AG$103,000,000
Indivior Inc.Indivior PLCprice-fixing or anti-competitive practices2023MULTI-AG$102,500,000
Mylan Laboratories, Inc.Viatrisconsumer protection violation2000FTC$100,000,000
Mallinckrodt ARD IncMallinckrodtprice-fixing or anti-competitive practices2017FTC$100,000,000
Astellas Pharma US Inc.Astellas PharmaFalse Claims Act and related2019DOJ_CIVIL$100,000,000
Bristol-Myers Squibb Co.Bristol-Myers Squibbprice-fixing or anti-competitive practices2003MULTI-AG$100,000,000
Mallinckrodt plcMallinckrodtprice-fixing or anti-competitive practices2017MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $100,000,000
Organon USA Inc.Organon & Co.drug or medical equipment safety violation2018private lawsuit-federal$100,000,000
GlaxoSmithKline PLCGlaxoSmithKlineprice-fixing or anti-competitive practices2005private lawsuit-federal$100,000,000
NovartisNovartiswage and hour violation2012private lawsuit-federal$99,000,000
Janssen PharmaceuticalsJohnson & Johnsonoff-label or unapproved promotion of medical products2022WV-AG$99,000,000
Astellas Pharma US, Inc.Astellas Pharmaprice-fixing or anti-competitive practices2015private lawsuit-federal$98,000,000
Gilead Sciences, Inc.Gilead SciencesFalse Claims Act and related2020DOJ_CIVIL$97,000,000
Mylan Inc.Viatrisprice-fixing or anti-competitive practices2018private lawsuit-federal$96,525,000
Aventis Pharmaceutical Inc.SanofiFalse Claims Act and related2009DOJ_CIVIL$95,500,000
Boehringer Ingelheim Pharmaceuticals Inc.Boehringer Ingelheimoff-label or unapproved promotion of medical products2012FDA$95,000,000
Boehringer-Ingelheim Pharmaceuticals, Inc.Boehringer Ingelheimoff-label or unapproved promotion of medical products2012MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $95,000,000
Pfizer Inc.Pfizerprice-fixing or anti-competitive practices2018private lawsuit-federal$94,000,000
GlaxoSmithKline PLCGlaxoSmithKlineprice-fixing or anti-competitive practices2004private lawsuit-federal$92,000,000
Schering-Plough CorporationMerckoff-label or unapproved promotion of medical products2006MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $91,602,000
GlaxoSmithKline LLCGlaxoSmithKlinedrug or medical equipment safety violation2012MULTI-AG$90,000,000
Johnson & JohnsonJohnson & Johnsondrug or medical equipment safety violation2004private lawsuit-federal$90,000,000
AstraZeneca Pharmaceuticals LPAstraZenecaprice-fixing or anti-competitive practices2011private lawsuit-federal$90,000,000
Novartis Pharmaceuticals CorporationNovartisoff-label or unapproved promotion of medical products2010MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $88,258,694
Scios Inc.Johnson & Johnsonoff-label or unapproved promotion of medical products2011FDA$85,000,000
Teva PharmaceuticalsTeva Pharmaceutical IndustriesControlled Substances Act violation2019OK-AG$85,000,000
Sandoz Inc.Sandoz Groupprice-fixing or anti-competitive practices2020private lawsuit-federal$85,000,000
Depuy Orthopaedics Inc.Johnson & JohnsonFalse Claims Act and related2007USAO$84,700,000
Novartis Pharmaceuticals CorporationNovartiskickbacks and bribery2015MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $83,129,754
Teva Pharmaceutical IndustriesTeva Pharmaceutical Industriesoff-label or unapproved promotion of medical products2022WV-AG$83,000,000
Ortho-McNeil Pharmaceutical LLCJohnson & Johnsonoff-label or unapproved promotion of medical products2010FDA$81,000,000
Watson Pharmaceuticals, Inc.Teva Pharmaceutical Industriesprice-fixing or anti-competitive practices2012private lawsuit-federal$79,000,000
AllerganAbbVieoff-label or unapproved promotion of medical products2022WV-AG$78,000,000
Bristol-Myers SquibbBristol-Myers SquibbFalse Claims Act and related2021USAO$75,000,000
Bristol Myers Squibb Co.Bristol-Myers SquibbFalse Claims Act and related2021MULTI-AG$75,000,000
GlaxoSmithKlineGlaxoSmithKlineprice-fixing or anti-competitive practices2005private lawsuit-federal$75,000,000
Organon Inc.Organon & Co.price-fixing or anti-competitive practices2005private lawsuit-federal$75,000,000
Boehringer Ingelheim Pharma GmbHBoehringer Ingelheimprice-fixing or anti-competitive practices2017private lawsuit-federal$73,000,000
Teva Pharmaceuticals USA Inc.Teva Pharmaceutical Industriesprice-fixing or anti-competitive practices2017private lawsuit-federal$73,000,000
Novartis Vaccines & Diagnostics Inc. and Novartis Pharmaceuticals CorporationNovartisoff-label or unapproved promotion of medical products2010FDA$72,500,000
Abbott LaboratoriesAbbVieprice-fixing or anti-competitive practices2005private lawsuit-federal$72,500,000
Teva Pharmaceuticals, Inc.Teva Pharmaceutical Industriesoff-label or unapproved promotion of medical products2023KY-AG$71,477,474
(*): Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting.